TechCrunch
DECEMBER 20, 2021
4 strategies for building a digital health unicorn. The virtual state of corporate venture capital today. The digital healthcare revolution has already begun, and it will gain further momentum in 2022 as providers and patients look for new and better ways to improve care. More posts by this contributor.
TechCrunch
APRIL 6, 2022
As a venture firm that invests in psychedelics, we receive hundreds of pitches every month from founders developing psychedelic therapeutics. Our fund has invested more than $15 million in companies developing psychedelic therapeutics. Greg Kubin is a partner at PsyMed Ventures and co-host of Business Trip.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
HPA
MARCH 15, 2022
We’re excited to share that metaMe Health , a prescription digital therapeutics (PDT) company, today announced raising $2.2M metaMe Health is the developer of Regulora®, the first FDA-authorized PDT specifically for abdominal pain associated with Irritable Bowel Syndrome (IBS) in adults. “We in funding.
HPA
MARCH 15, 2022
We’re excited to share that metaMe Health , a prescription digital therapeutics (PDT) company, today announced raising $2.2M metaMe Health is the developer of Regulora®, the first FDA-authorized PDT specifically for abdominal pain associated with Irritable Bowel Syndrome (IBS) in adults. “We in funding.
TechCrunch
NOVEMBER 3, 2021
BrainCheck , a Houston- and Austin-based company developing cognitive healthcare software to aid physicians in detecting and managing this type of care, raised $10 million in Series B funding to expand its R&D and go-to-market capabilities as it works on new digital therapeutics for Alzheimer’s and related dementias.
TechCrunch
MAY 12, 2023
Amongst these questions are actual costs of therapies, reimbursement coverage, the commercialisation strategy for psychedelic drug development companies, resource bottlenecks with the therapists’ supply and infrastructure, etc,” they told TechCrunch+. is not the only place where psychedelics are seeing interest. Will they take the lead?”
Angel Capital Association
MAY 18, 2020
By Sarah Dickey, ACA Membership Director Young company awarded prestigious Luis Villalobos Award, Life Sciences category, from Angel Capital Association “Where words fail, music speaks.” The company is now advancing its hardware and software solution through the FDA approval process. “As How does MedRhythms’ technology work?
Expert insights. Personalized for you.
136 
Let's personalize your content